International Murex Technologies Corp. said that it raised anadditional $10 million through the exercise of an overallotmentoption by its underwriters.
The underwriters, led by Deacon Barclays de Zoete Wedd Ltd.,exercised the 890,000-share option at $11.25 per share,bringing to $45 million the total raised from the company'soffering of shares in Europe and the Far East.
Murex (AMEX:MXX), which develops diagnostics for infectiousdiseases and blood bank products, now has 14.9 million sharesoutstanding.
The stock has also been added to the Toronto Stock Exchange300 Composite Index. The Toronto company's shares closed at$14.13, up 13 cents, on Thursday.
(c) 1997 American Health Consultants. All rights reserved.